Credits Available: 4.25 AMA PRA Category 1 Credits™, 4.25 ANCC Contact Hours, 4.25 ACPE

Description: This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of goal-concordant care using shared decision-making strategies. A challenging real-world case scenario discussion within each Gather-ed group highlights critical decision points, key challenges, and opportunities to incorporate collective insights.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Pharmacist, Physician Assistant, Nurse, Pharmacy Director
Target Specialties: Hematology, Hematology/Oncology, Oncology
Group Leader

David Bond

The Ohio State- The James
MD

I am a hematologist who specializes in treating patients with Hodgkin’s and non-Hodgkin’s lymphoma. I received my doctor of medicine from the Indiana University School of Medicine and completed my internal medicine residency and hematology and medical oncology fellowship at The Ohio State University.

 

Group Co-Leader

Gai Mei Wong

The Ohio State Wexner Medical Center James Comprehensive Cancer Center

I am a Physician Assistant/Associate and treat non-Hodgkin and Hodgkin lymphoma patients at the Ohio State University Wexner Medical Center James Comprehensive Cancer Center in Columbus, Oh. I attended The Ohio State University and received an undergraduate degree in Industrial Systems Engineering. I attended Western University of Health Sciences and received a Master of Science in Physician Assistant Studies. I have over a decade of experience treating both hematology and oncology patients.